sPLA2 inhibition to decrease enzyme release after PCI trial (SPIDER-PCI).
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Varespladib (Primary)
- Indications Myocardial infarction; Myocardial reperfusion injury
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms SPIDER-PCI
- 05 Apr 2011 Results presented at the 60th Annual Scientific Session of the American College of Cardiology.
- 15 Mar 2010 Results were presented at the 59th Annual Scientific Session of the American College of Cardiology.
- 14 Oct 2009 Actual end date (Jun 2009) added as reported by ClinicalTrials.gov.